Aditxt, Inc. (ADTX): Free Cash Flow
-$25.70M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$25.70M | n/a | 2026-03-31, From 2025-01-01 |
| No annual figure between 2023-12-31 and 2025-12-31. | |||
| 2023-12-31 | -$19.22M | n/c | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$22.76M | n/a | 2024-04-16, From 2022-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$25.70M | n/a |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$2.97M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$26.37M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$3.96M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$534.0K | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$42.5K | n/m |
| Talphera, Inc. (TLPH) | 2024-12-31 | -$12.68M | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$150.80M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$20.86M | n/a |
Compare ADTX, TCRT, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗